depatuxizumab mafodotin inn development code antibodydrug conjugate designed treatment composed egfr monoclonal antibody depatuxizumab conjugated tubulin inhibitor monomethyl auristatin f via stable maleimidocaproyl drug developed abbvie may abbvie stopped enrolment studies depatuxm latestage failure newly diagnosed orphan drug status granted fda glioblastoma phase iiiii clinical trials glioblastoma phase ii clinical trials nonsmall cell lung cancer phase clinical trials treatment solid phase results presented asco monoclonal article stub help wikipedia expanding ithttpsenwikipediaorgwikidepatuxizumabmafodotin